Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1060 of 5804
-
New antibody aims to supercharge immune system against cancer
Disease control Recruiting nowThe STARLYS trial is an adaptive, modular, Phase 1, open-label, multi-part, clinical trial evaluating MST-0312 in selected solid tumors. MST-0312 is a targeted bispecific antibody that is designed to locally stimulate the lymphotoxin beta receptor (LTBR) in order to boost the bod…
Phase: PHASE1 • Sponsor: Mestag Therapeutics Limited • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Brain implant learns to fight Parkinson's symptoms around the clock
Symptom relief Recruiting nowThe purpose of this study is to test a new way to treat Parkinson's disease (PD). Subjects will be implanted with deep brain stimulator (DBS) devices and electrodes placed under the scalp. The main questions it aims to answer are: * Is there a less invasive method to collect us…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Can a phone app help women at risk of HIV start PrEP?
Prevention Recruiting now(Effectiveness Aim 1) To test the comparative effectiveness of PreP for WINGS versus PrEP alone on primary outcomes of increasing PrEP initiation measured by self-report/medical records, recent adherence and longer-term adherence by self-report/medical records over the 6-month fo…
Phase: NA • Sponsor: Columbia University • Aim: Prevention
Last updated Jun 27, 2026 14:01 UTC
-
Gut bacteria boost may slash heart surgery recovery time
Disease control Recruiting nowMore than 7.4 million people in the UK are currently waiting for surgery. Behind that number are real people-patients preparing mentally and physically for procedures ranging from joint replacements to major heart and abdominal operations. This research forms part of a broader s…
Phase: NA • Sponsor: Hull University Teaching Hospitals NHS Trust • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Spinal zaps may help stiff legs move freely in rare nerve disease
Symptom relief Recruiting nowHereditary spastic paraplegia (HSP) is a rare neurological condition that causes stiffness, weakness, and difficulty walking due to damage in the nerves that control movement. This study will test whether a noninvasive form of spinal cord stimulation, called transcutaneous spinal…
Phase: NA • Sponsor: Rahul Sachdeva • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Heat therapy may tame parathyroid Cancer's calcium chaos
Disease control Recruiting nowThe study will be an effectiveness study. The study will include enrollment of a total of 20 patients with at least one PC lesion for ultrasound guided RFA to PC recurrence in the neck to assess the effectiveness in reducing patient's hypercalcemia. Patients will have surgically …
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Weight-Loss drug may cool menopause hot flashes and reverse aging clock
Symptom relief Recruiting nowThe purpose of this study is to determine the effect of tirzepatide on vasomotor symptoms and on measures of biological aging.
Phase: PHASE4 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
New drug duo aims to supercharge immune attack on head and neck tumors before surgery
Disease control Recruiting nowThe goal of this clinical trial is to learn if drug CADI-05, when used together with pembrolizumab (an FDA approved immunotherapy), can help treat locally advanced head and neck squamous cell carcinoma (LA-HNSCC) in adults. It will also learn about the safety of drug CADI-05. The…
Phase: PHASE1 • Sponsor: Fox Chase Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New drug combo shows promise for tough gynecological cancers
Disease control Recruiting nowThis is an open-label, multicenter, Phase II clinical study to evaluate the efficacy and safety of SKB518 as monotherapy or combination therapy in patients with advanced gynecological malignancies. This study will include 5 cohorts: SKB518 as monotherapy in advanced ovarian canc…
Phase: PHASE2 • Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
ERs could become frontline for HIV prevention: new study tests immediate PrEP
Prevention Recruiting nowOur primary objective is to increase HIV pre-exposure prophylaxis (PrEP) awareness and uptake among people who want, need, or would benefit from PrEP in Dallas, TX through a pilot program of immediate PrEP prescribing in the Parkland Memorial Hospital Emergency Department (ED) wi…
Phase: NA • Sponsor: University of Texas Southwestern Medical Center • Aim: Prevention
Last updated Jun 27, 2026 13:00 UTC
-
Sickle cell kidney hope: common diabetes drug tested to save kidneys
Disease control Recruiting nowSickle cell anemia (SCA) is an inherited red blood disorder. The kidneys are among the most commonly affected organ systems in SCA. The Food and Drug Administration (FDA) has approved empagliflozin as a treatment to reduce the decline of kidney function in those with kidney disea…
Phase: PHASE2 • Sponsor: University of Illinois at Chicago • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New drug xaluritamig takes on tough ewing sarcoma in early trial
Disease control Recruiting nowThe main objectives of this trial are to determine the recommended dose for expansion of xaluritamig (dose confirmation part only) and to determine the safety and tolerability of xaluritamig in adult, adolescent and pediatric participants with relapsed or refractory EWS.
Phase: PHASE1 • Sponsor: Amgen • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Can quick drug optimization after heart failure hospitalization save lives in women?
Disease control Not yet recruitingThe goal of this clinical trial is to learn whether a rapid and intensive optimization of heart failure medications in women can improve outcomes after hospitalization for heart failure. It will also investigate the safety and the tolerance of these treatments when given at full …
Phase: PHASE4 • Sponsor: IRCCS Policlinico S. Donato • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New prostate cancer combo aims to shrink tumors and lower PSA
Disease control Recruiting nowThe study aims to assess the safety and tolerability of SHR-4394 in combination with anti-tumor therapy in participants with prostate cancer, and determine the recommended Phase II dose (RP2D); To evaluate of the efficacy of SHR-4394 in combination with anti-tumor therapy in part…
Phase: PHASE1, PHASE2 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can a mirror and a robot glove restore hand movement after stroke?
Symptom relief Recruiting nowPost-stroke hemiplegia frequently results in impaired upper limb function, which significantly affects independence and quality of life. Various rehabilitation approaches have been developed to improve motor recovery, including mirror therapy and robotic-assisted training. Mirror…
Phase: NA • Sponsor: University of Baghdad • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
Pneumonia drug trial aims to protect arteries from hidden damage
Disease control Recruiting nowThe goal of this clinical trial is to learn if icosapent ethyl (Vascepa) works to lessen the amount of inflammation in adults diagnosed with Community-Acquired Pneumonia (CAP). The main question it aims to answer is: What is the effect of taking Vascepa on inflammation in the ar…
Phase: PHASE3 • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Could adding bismuth boost stomach bug treatment?
Disease control Recruiting nowThis study aims to compare the efficacy and safety of a bismuth-supplemented 14-day vonoprazan-based dual therapy ( triple therapy) versus a 14-day vonoprazan-based dual therapy without bismuth for first-line H. pylori eradication. Furthermore, the investigators will investigate …
Phase: PHASE3 • Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Blood test strategy aims to cut TB treatment dropouts
Disease control Recruiting nowThis study is a two-arm, pragmatic, open-label, randomized clinical trial to determine the efficacy of Therapeutic Drug Monitoring (TDM) in preventing premature discontinuation of Linezolid (LZD) in participants with Rifampicin-resistant tuberculosis (RR-TB). Following the initia…
Phase: NA • Sponsor: Albert Einstein College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New drug cocktail targets Hard-to-Treat cancers with genetic flaw
Disease control Recruiting nowThe researchers are doing this study to test the safety of BMS-986504 in combination with standard disease-specific anticancer medication in people with metastatic/advanced unresectable MTAP-deleted solid tumor cancer.
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Family support program aims to stop child labor before it starts
Prevention Recruiting nowThis study seeks to address the urgent need for theoretically and empirically informed interventions that would address the increasing numbers of unaccompanied minors migrating from rural to urban centers in developing countries for better economic opportunities. This process oft…
Phase: NA • Sponsor: New York University • Aim: Prevention
Last updated Jun 27, 2026 12:06 UTC